The function of RPL5 and RPL11 in induction of P53
Ended Cooperative Agreement Awarded Last action
- Award ID
- R01CA158768
- Recipient
-
Fundacio Institut D Investigacio Biomedica De Bellvitge Idibell UEI T24CKEMW3Q93
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,478,341
Award facts
- Assistance listing
- 93.396 Cancer Biology Research
- Completion date
- Originally
- Place of performance
- Spain
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$19,540 | |
| Amendment | $22,410 | |
| Amendment | $201,690 | |
| Amendment | -$165,240 | |
| Amendment | $165,240 | |
| Amendment | $325,775 | |
| Amendment | $22,804 | |
| Amendment | $293,198 | |
| Amendment | $159,630 | |
| Amendment | $146,599 | |
| Original award | $325,775 |
Show all 11
Quick answers
Who received award R01CA158768?
R01CA158768 was awarded to Fundacio Institut D Investigacio Biomedica De Bellvitge Idibell by National Cancer Institute (National Institutes of Health) on March 1, 2012.
How much is award R01CA158768 worth?
$1,478,341 has been obligated on R01CA158768.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award